PALVELLA THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wayne, PA
SEC filing record 1 source field available
Fiscal year end
31 December
PALVELLA THERAPEUTICS, INC. has filed 807 SEC EDGAR filings since 20 Aug 2013

SEC filing history

Showing 151-175 of 807 matching filings.

Per page
25
Current page
7
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 (GERAGHTY SERIES F)

Filing date
12 Dec 2024
Reporting date
12 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37471

FORM 425

Filing date
12 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 (ANNUAL GRANT)

Filing date
09 Dec 2024
Reporting date
02 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88917

SCHEDULE 13G/A filing

Filing date
06 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37471

FORM 425

Filing date
03 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
18 Nov 2024
Reporting date
06 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88917

PIERIS PHARMACEUTICALS, INC.

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-281459

EFFECT filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-281459

FORM 424B3

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-37471

FORM 425

Filing date
07 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-4/A File 333-281459

FORM S-4/A

Filing date
07 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37471

FORM DEF 14A

Filing date
06 Nov 2024
Reporting date
02 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-37471

FORM ARS

Filing date
06 Nov 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .